Mail-order drug pharmacy Medco Health Solutions will have a “monster” year, meaning a very lucrative one, in 2012, due to a number of blockbuster drugs going off-patent, David Snow, its CEO and chairman, told CNBC Monday.
“In November, we mapped out the relative incremental contributions over the entire decade to 2020,” added Snow, who was speaking from the JP Morgan Healthcare Conference in San Francisco. “You’re going to see upwards of 60 cents a share for us easily in that zone.
“And it’s not just Lipitor [which treats high cholesterol]: We get the full-year impact in ‘2012, one month impact in ‘2011, but you also have the Number 3 drug in the world, Plavix [which is used to prevent strokes and heart attacks], going off-patent. There are actually five other drugs going off-patent in '12. It’s [going to be] a very big year.”